Preparation and Storage
推奨アッセイ手順
The biotinylated I52-278 antibody is useful as a detector antibody for a sandwich ELISA that measures mouse C5a protein levels. Purified I52-1486 as capture antibody (Cat. No. 558027) can be paired with the biotinylated I52-278 anti-mouse C5a as the detection antibody, using purified recombinant mouse C5a protein (Cat. No. 622597) as standard. The biotinylated I52-278 antibody should be titrated between 0.25-2 µg/ml to determine its optimal ELISA detection concentration. To obtain linear standard curves, doubling dilutions of purified mouse C5a protein ranging from 156 pg to 10 ng/ml are recommended for inclusion in each ELISA plate. PBS with 10%FCS is recommended as the blocking buffer. Addition of FUT-175 (Futhan), Cat. No. 552035, to plasma samples at the time of sample collection provides additional protection from ex-vivo activation, and therefore ensures more accurate measurements that reflect the circulating levels of complement activation products. For specific methodology and ELISA buffer recipes, see Immune Function Handbook which is posted on the website at www.bdbiosciences.com. This ELISA antibody pair shows no cross-reactivity with the following: recombinant mouse C3a, native human, and rat C5a.
Product Notices
- Since applications vary, each investigator should titrate the reagent to obtain optimal results.
- Please refer to www.bdbiosciences.com/us/s/resources for technical protocols.
- Caution: Sodium azide yields highly toxic hydrazoic acid under acidic conditions. Dilute azide compounds in running water before discarding to avoid accumulation of potentially explosive deposits in plumbing.
関連製品
The I52-278 monoclonal antibody reacts with the mouse C5a protein. Clone I52-278 hybridoma was generated by the fusion of spleen cells from rats immunized with recombinant mouse C5a protein. Anaphylatoxin C5a is a bioactive cleavage product released from plasma component C5 during complement activation and is involved in mediation of a variety of cellular immune responses, as well as being potent pro-inflammatory agents. The release of this cleavage product is a reliable indicator of in vivo or in vitro complement activation.
This antibody is routinely tested by ELISA detection. Other applications were tested at BD Biosciences Pharmingen during antibody development only or reported in the literature.
Development References (3)
-
Ember JA., Jagels MA., Hugli TE. Characterization of complement anaphylatoxins and their biological responses. In: J.E. Volanakis and M.M. Frank, ed. The human complement system in health and disease. Marcel Dekker, Inc; 1998:241-284.
-
Hugli TE. Structure and function of the anaphylatoxins. Springer Semin Immunopathol. 1984; 7:193-219. (Biology). View Reference
-
Volanakis, J.E. Overview of the complement system. In.: The human complement system in health and disease. In: J.E. Volanakis and M.M. Frank, ed. Marcel Dekker, Inc.; 1998:9-32.
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
For Research Use Only. Not for use in diagnostic or therapeutic procedures.
